DDR2 Antibody

1. Our data indicate that DDR2 is a potent biomarker that can be used as an effective therapeutic target for treating oral squamous cell carcinoma patients with lymph node metastasis. PMID:29945346
2. DDR2 localisation is independent of integrin activation and the key DDR2 signalling effector SHC1. Structure-function analysis reveals that DDR2 mutants defective for collagen binding or kinase activity are unable to localise to the cell surface, demonstrating for the first time that both collagen binding and kinase functions are required for spatial localisation of DDR2. PMID:29709482
3. report the identification and characterization of a selective, extracellularly acting small molecule inhibitor (WRG-28) of DDR2 that uniquely inhibits receptor-ligand interactions via allosteric modulation of the receptor. By targeting DDR2, WRG-28 inhibits tumor invasion and migration PMID:30061414
4. Our results suggest that a mutation in DDR2 occurs naturally with a frequency of about 2% in Korean lung SCC patients. In addition, we showed that each of the novel DDR2 mutations were located in a kinase domain and induced an increase in cell proliferation rate. PMID:28161936
5. Overexpression of DDR2 might contribute to tumor progression in lung SQCC. The overexpression of DDR2 could be potential molecular target of lung SQCC. PMID:28676216
6. DDR2 overexpression is independently associated with tumor progression and poor survival rates in urothelial carcinoma patients. PMID:27793038
7. The DDR2 E655K mutation can play a role in cancer progression. PMID:26826182
8. collagen II-activated phosphorylated-DDR2 induces CYR61 through activation of transcription factor activator protein 1 (AP-1). The elevated CYR61, in turn, accelerates MMP1 production via ETS1 (ETS proto-oncogene 1). PMID:27653023
9. these data suggest that biological collagen aging could increase tumor cell proliferation by reducing the activation of the key matrix sensor DDR2 PMID:27121132
10. Female ddr2-deficient mice homozygous for the slie mutation show inefficient spontaneous BC metastasis. PMID:28147276
11. This study suggested that DDR1 and DDR2 knockdown alters brain immunity and significantly reduces the level of triggering receptor expressed on myeloid cells (TREM)-2 and microglia. PMID:28863860
12. This work identifies DDR2 as a potential therapeutic target that controls breast cancer metastases through its action in both tumor cells and tumor-stromal cells at the primary tumor site. PMID:27264173
13. The group of patients with colorectal cancer with high DDR2 expression had significantly higher frequencies of T4, lymph node metastasis, and peritoneal dissemination compared to the group with low DDR2 expression. PMID:28476831
14. DDR2 showed high expression in gastric cancer tissues and cells. In xenograft models, DDR2 overexpression promoted tumor formation. Furthermore, DDR2 expression impacted on the invasion and motility of GC cells, accompanied by changes in EMT marker expression. Finally, our results revealed that DDR2 facilitates GC cell invasion and EMT through mTORC2 activation and AKT phosphorylation. PMID:27010547
15. DDR2 mediates collagen-induced activation of MT1-MMP in human fibroblasts PMID:28270508
16. Study strongly suggests that during pulmonary fibrosis, DDR2 not only participates in both the initiation and maintenance of fibrotic reaction, but also affects both ECM production and angiogenesis. PMID:27350126
17. signaling pathway, effectively suppressed peritoneal dissemination. DDR2 was identified as a driver gene for Gastric Cancer dissemination from the combined expression signature and can potentially serve as a novel therapeutic target for inhibiting Gastric Cancer peritoneal dissemination. PMID:26934957
18. DDR2 Missense mutation is associated with spondylo-meta-epiphyseal dysplasia, short limb-abnormal calcification type. PMID:26463668
19. Data suggest SCl2 (Streptococcus pyogenes) binds to DDR (DDR1, DDR2) ectodomain w/o stimulating receptor signaling; here, protein engineering was used to construct SCl-like proteins that inhibit collagen-DDR interactions and macrophage migration. PMID:26702058
20. DDR2 plays an important role in promoting hepatocellular carcinoma cell invasion and migration by stabilizing SNA1. PMID:26362312
21. The inhibition of DDR2 by RNA interference suppressed in vivo and in vitro growth of human hepatocellular carcinoma cells. PMID:25842034
22. Report correlation between increased radiographic grade of knee osteoarthritis and decreased proportion of cartilage stained for DDR2. PMID:26191278
23. Identified are 3 Single Nucleotide Polymorphisms in DDR2 significantly associated with hip bone mineral density in the Chinese population. PMID:25658585
24. Defective Ca(2+) binding in a conserved binding site causes incomplete N-glycan processing and endoplasmic reticulum trapping of DDR1 and DDR2 receptors. PMID:25470979
25. Data show that discoidin domain receptor 2 (DDR2) is linked to a polyubiquitin (Ub) chain predominantly through lysine K27 conjugation and slightly through K33. PMID:26271983
26. In ADSCC patients, DDR2 mutation coexisted with G12C substitution in KRAS gene. PMID:25173530
27. peptide delivered by the AuNP-Apt system inhibited cancer cell proliferation and invasion mediated by DDR2 activation PMID:26067556
28. A DDR1(Low)/DDR2(High) protein profile is associated with TNBC and may identify invasive carcinomas with worse prognosis. PMID:25667101
29. DDR2 signaling regulates cell proliferation and extracellular matrix synthesis, which are key aspects of fibroblast contribution to tissue healing [review] PMID:24781958
30. DDR2 promoted chondrocyte hypertrophy and terminal differentiation. PMID:24938620
31. DDR2 plays an important role in head and neck squamous cell carcinoma metastasis, and might be a promising target for future therapies in this type of cancer. PMID:24556606
32. These data indicated that the novel DDR2 mutation may contribute to the development and progression of lung SCC and this effect may be associated with increased proliferation and invasiveness, at least in part, via regulating E-cadherin expression. PMID:24885564
33. Our results highlight potential RTK-driven adaptive-resistant mechanisms upon DDR2 targeting, and they suggest new, rationale cotargeting strategies for DDR2-mutant lung squamous cell cancer PMID:25348954
34. Promising therapeutic opportunities based on existing and novel targeted small molecule inhibitors against DDR2 may provide new strategies for treating lung squamous cell cancer patients. PMID:24828669
35. High DDR2 protein expression is associated with recurrence in ameloblastomas. PMID:24723326
36. we conclude that DDR2 participates in hypoxia-induced breast cancer metastasis through the regulation of cell migration, invasion, and epithelial-mesenchymal transition PMID:25130389
37. In this review we highlight the mechanisms whereby DDRs(DDR1 and DDR2) regulate two important processes, namely inflammation and tissue fibrosis. PMID:24361528
38. DDR2 overexpression is associated with neoplasms. PMID:24740739
39. Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements. PMID:24505276
40. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein. PMID:24787381
41. Cbl-b, by promoting the ubiquitination and degradation of DDR2, functions as a negative regulator in the DDR2 signaling pathway. PMID:24631539
42. A novel missense deletion mutation in DDR2 causing spondylo-meta-epiphyseal dysplasia with short limbs and abnormal calcifications (SMED-SL) results in defective intra-cellular trafficking. PMID:24725993
43. regulation of DDRs by glucose PMID:24018687
44. Loss of DDR2 suppresses tumor angiogenesis and tumor metastasis to the lung. PMID:24293323
45. SHP-2 is a key signalling node downstream of the DDR2 receptor in lung cancer. PMID:23822953
46. DDR2 functioning is required for the membrane dynamics to control the mechanical attachment of fibroblasts to the 3D collagen matrices in an integrin-independent manner. PMID:23546533
47. DDR2 maintains SNAIL1 level and activity in tumour cells that have undergone epithelial-mesenchymal transition (EMT), thereby facilitating continued tumour cell invasion through collagen-I-rich extracellular matrices by sustaining the EMT phenotype. PMID:23644467
48. DDR2 is an independent favorable predictor for prognosis in human breast cancer. PMID:23307244
49. Mutations in the DDR2 gene were recently identified in squamous cell lung cancer through a sequencing screen of 201 genes with a potential role in human cancer (including the entire tyrosine kinome). PMID:23401445
50. DDR2 regulates directionality through its ability to increase secretion of metalloproteinases and local generation of collagen-derived chemotactic peptide gradients. PMID:23233663

Show More

Hide All

HGNC: 2731

UNIGENE: Hs.275757

KEGG: hsa:4921

STRING: 9606.ENSP00000356898

OMIM: 191311